Analysts call end to horror run for healthcare giant CSL as share price finds a floor at decade low
The horror run for Australian healthcare giant CSL may be over after its share price hit a decade low, analysts say, expecting material gains from its cost reduction program.
The West Sport
7NEWS Australia 
The Sydney Morning Herald 
Daily Telegraph 
